Literature DB >> 15870693

Gene expression-based classification of nonseminomatous male germ cell tumors.

James E Korkola1, Jane Houldsworth, Debbie Dobrzynski, Adam B Olshen, Victor E Reuter, George J Bosl, R S K Chaganti.   

Abstract

Male adult germ cell tumors (GCTs) comprise two major histologic groups: seminomas and nonseminomas. Nonseminomatous GCTs (NSGCTs) can be further divided into embryonal carcinoma (EC), teratoma (T), yolk sac tumor (YS), and choriocarcinoma (CC) on the basis of the lineage differentiation that they exhibit. NSGCTs frequently present as mixed tumors consisting of two or more histological subtypes, often limiting correlative studies of clinical and molecular features to histology. We sought to develop a molecular classifier that could predict the predominant histologic subtype within mixed NSGCT tumor samples. The expression profiles of 84 NSGCTs (42 pure and 42 mixed) and normal age-matched testes were obtained using Affymetrix microarrays. Using prediction analysis for microarrays, we identified 146 transcripts that classified the histology of pure NSGCTs samples with 93% accuracy. When applied to mixed NSGCTs, the classifier predicted a histology that was consistent with one of the reported components in 93% of cases. Among the predictive transcripts were CGB (high in CC), LCN2 (high in T), BMP2 (high in YS), and POU5F1 (high in EC). Thus, the expression-based classifier accurately assigned a single predominant histology to mixed NSGCTs, and identified transcripts differentially expressed between histologic components with relevance to NSGCT differentiation.

Entities:  

Mesh:

Year:  2005        PMID: 15870693     DOI: 10.1038/sj.onc.1208694

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

Review 1.  Testicular germ cell tumours: predisposition genes and the male germ cell niche.

Authors:  Duncan Gilbert; Elizabeth Rapley; Janet Shipley
Journal:  Nat Rev Cancer       Date:  2011-03-17       Impact factor: 60.716

2.  Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency.

Authors:  Ritu Kushwaha; Nirmala Jagadish; Manjunath Kustagi; Mark J Tomishima; Geetu Mendiratta; Mukesh Bansal; Hyunjae R Kim; Pavel Sumazin; Mariano J Alvarez; Celine Lefebvre; Patricia Villagrasa-Gonzalez; Agnes Viale; James E Korkola; Jane Houldsworth; Darren R Feldman; George J Bosl; Andrea Califano; R S K Chaganti
Journal:  Stem Cells       Date:  2015-02       Impact factor: 6.277

3.  microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer.

Authors:  Bi-Feng Chen; Shen Gu; Yick-Keung Suen; Lu Li; Wai-Yee Chan
Journal:  Epigenetics       Date:  2013-08-19       Impact factor: 4.528

4.  Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.

Authors:  Caryl J Giuliano; Sarah J Freemantle; Michael J Spinella
Journal:  Curr Cancer Ther Rev       Date:  2006-08-01

Review 5.  Testicular cancer: biology and biomarkers.

Authors:  Leendert H J Looijenga; Hans Stoop; Katharina Biermann
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

6.  The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis.

Authors:  Patrick A Carroll; Brian W Freie; Pei Feng Cheng; Sivakanthan Kasinathan; Haiwei Gu; Theresa Hedrich; James A Dowdle; Vivek Venkataramani; Vijay Ramani; Xiaoying Wu; Daniel Raftery; Jay Shendure; Donald E Ayer; Charles H Muller; Robert N Eisenman
Journal:  PLoS Biol       Date:  2021-10-20       Impact factor: 9.593

7.  Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors.

Authors:  James E Korkola; Jane Houldsworth; Darren R Feldman; Adam B Olshen; Li-Xuan Qin; Sujata Patil; Victor E Reuter; George J Bosl; R S K Chaganti
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

Review 8.  [Advances in basic research on testicular germ cell tumors : clinical implications].

Authors:  L H J Looijenga
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

9.  Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation.

Authors:  Martina Benešová; Kateřina Trejbalová; Dana Kučerová; Zdenka Vernerová; Tomáš Hron; Arpád Szabó; Rachel Amouroux; Petr Klézl; Petra Hajkova; Jiří Hejnar
Journal:  Mol Carcinog       Date:  2017-05-24       Impact factor: 4.784

10.  Gene expression profiling of rat spermatogonia and Sertoli cells reveals signaling pathways from stem cells to niche and testicular cancer cells to surrounding stroma.

Authors:  Stephan Ryser; Dominique Glauser; Michelle Vigier; Yong Qiang Zhang; Philippe Tachini; Werner Schlegel; Philippe Durand; Irmgard Irminger-Finger
Journal:  BMC Genomics       Date:  2011-01-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.